Guideline | Drug Name |
---|---|
Rozlytrek (entrectinib) | Rozlytrek (entrectinib) |
Rubraca (rucaparib) - PA, NF | Rubraca (rucaparib) |
Rybrevant (amivantamab) | Rybrevant (amivantamab) |
Rydapt (midostaurin) | Rydapt (midostaurin) capsules |
Ryplazim (plasminogen, human-tvmh) | Ryplazim (plasminogen, human-tvmh) |
Rystiggo (rozanolixizumab) | Rystiggo (rozanolixizumab) |
Rytelo (imetelstat) | Rytelo (imetelstat) |
Sabril, Vigadrone, Vigafyde, Vigpoder (vigabatrin) | Sabril (vigabatrin), Vigadrone (vigabatrin), Vigpoder (vigabatrin), Vigafyde (vigabatrin) |
Saphnelo (anifrolumab-fnia) | Saphnelo (anifrolumab-fnia) |
Sapropterin Products | Javygtor (sapropterin dihydrochloride), Kuvan (sapropterin dihydrochloride) |
Scemblix (asciminib) | Scemblix |
Scenesse (afamelanotide) | Scenesse (afamelanotide) |
Selzentry (maraviroc) | Selzentry (maraviroc) |
Sensipar (cinacalcet) | Sensipar (cinacalcet) |
Sernivo (betamethasone dipropionate) | Sernivo (betamethasone dipropionate) |
Sevenfact [coagulation factor VIIa (recombinant)-jncw]-NF | Sevenfact [coagulation factor VIIa (recombinant)-jncw] |
SGLT2 Inhibitors - ST, NF | Brenzavvy (bexagliflozin), Inpefa, Invokamet (canagliflozin/metformin), Invokamet XR (canagliflozin/metformin), Invokana (canagliflozin), Qtern (dapagliflozin and saxagliptin), Segluromet (ertugliflozin and metformin), Steglatro (ertugliflozin), Steglujan (ertugliflozin and sitagliptin) |
Short Acting Insulin - ST, NF | Humalog (insulin lispro), Lyumjev (insulin lispro-aabc), Novolin (human insulin), Novolog (insulin aspart) |
Signifor, Signifor LAR (pasireotide) - PA, NF | Signifor (pasireotide), Signifor LAR (pasireotide) |
Siklos (hydroxyurea) | Siklos (hydroxyurea) |